Purchase Order 36C24226P0423
Award Date 2/26/26
Potential Completion Date 3/5/26
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Memphis, TN 38141, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer, received a delivery order valued at $16,421.95 for Pomalidomide (Pomalyst) 4mg capsules from Veterans Integrated Service Network 5 (VISN 5), a civilian component of the Department of Veterans Affairs. This firm fixed-price contract, awarded on February 3, 2026, with an ultimate completion date of February 6, 2026, carries no set-aside designation. The order will be fulfilled from the company's Lawrenceville, New Jersey...
- Covermymeds Pharmacy LLC was awarded a firm fixed-price purchase order valued at $872,325.86 by the Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the Department of Veterans Affairs. The contract, awarded on January 16, 2026, with an ultimate completion date of April 17, 2026, covers pharmacy services to be performed in Memphis, Tennessee. No set-aside designation was applied to this award. VISN 8 serves veterans across a multi-state region and coordinates healthcare...
- Bristol-Myers Squibb Company received a delivery order from Veterans Integrated Service Network 5 (VISN 5) valued at $10,887.52 for the supply of Pomalyst 3mg capsules, a specialty oncology pharmaceutical used in the treatment of multiple myeloma and related hematologic malignancies. The award, issued on February 26, 2026, with an ultimate completion date of March 6, 2026, was made under a firm fixed-price contract structure with no set-aside designation. This delivery order represents one of...
- The Defense Logistics Agency awarded a delivery order valued at $70,259.33 to AmerisourceBergen Drug Corp for the supply of Pomalyst 1 mg capsules (100-count units). This firm fixed-price delivery order, issued on August 29, 2025, represents a non-competitive, non-set-aside procurement and is scheduled for completion by September 22, 2025. The award will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pomalyst (pomalidomide) is an immunomodulatory...
- The Defense Logistics Agency awarded a delivery order valued at $27,703.52 to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Pomalyst (pomalidomide) 4 mg capsules in a 21-count package. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of October 20, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pomalyst 4 mg capsules (21-count units) with a ceiling value of $41,555.25. This firm fixed price delivery order, with an ultimate completion date of September 10, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pomalyst 4 mg capsules (21-count packages) on December 2, 2025, with a ceiling value of $43,792.86 and completion date of December 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $14,597.62 to AmerisourceBergen Drug Corp for the supply of Pomalyst 4 mg capsules (21-count units) on November 13, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded Incyte Corporation a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for a firm fixed price. The order is for PEMAZYRE 9 MG tablets to fulfill requirements under the referenced master agreement. Performance will take place in San Diego, California with completion by July 28, 2021. No set-aside provisions were applied to this...
- This is a $75,919.20 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Core Trading Co, a minority-owned, veteran-owned, service-disabled veteran-owned small business based in Chesapeake, Virginia. The contract is for the supply of pharmaceuticals, including cyclophosphamide, isosorbide, and dapsone, to the VA. The contract has an ultimate completion date of March 28, 2016 and was awarded on February 5, 2016. The contract did not utilize any set-aside...